The PURE study results, and their share of the unexpected
The PURE study measured grip strength with a Jamar dynamometer in 139,691 people from 17 countries, at all income levels. Over 4 years of median follow-up, 3,379 deaths. Each 5 kg reduction in strength is associated with 16% higher all cause mortality, 17% higher cardiovascular mortality, 7% higher risk of myocardial infarction and 9% higher risk of stroke.
The sentence that drew attention is elsewhere in the paper: grip strength is a better predictor of all cause mortality and cardiovascular mortality than systolic blood pressure. A three minute gesture, with no consumable, beats a measurement that everyone takes.
The association holds across country income strata, which rules out the hypothesis of a mere reflection of living standards. It does not hold for incident diabetes, pneumonia, falls or fractures: this marker does not predict everything.
Confirmation in half a million Britons
The UK Biobank took up the question in about half a million participants aged 40 to 69, 54% of them women, with 13,322 deaths over 7.1 years of mean follow-up. Per 5 kg less strength, all cause mortality rises by 20% in women and 16% in men.
The same gradient appears for cardiovascular mortality, respiratory mortality, chronic obstructive pulmonary disease, colorectal cancer and lung cancer. It does not appear for prostate cancer. Several of these associations are more marked in the younger members of the cohort, which argues against the idea of a marker reserved for old age.
The authors also tested the real predictive contribution: adding grip strength to a classic risk score made of age, sex, diabetes, body mass index, systolic pressure and smoking improves the concordance index by 0.013 for all cause mortality. That is a modest gain, at population scale.
The hierarchy of physical capacities
Before those two cohorts, a meta-analysis published in the British Medical Journal in 2010 had compared four measures of physical capability: grip strength, walking speed, chair rising and one leg standing balance. All four are associated with mortality.
For grip strength, 14 studies and 53,476 participants give a mortality risk 1.67 times higher in the lowest quartile than in the highest, after adjustment for age, sex and body size.
The practical interest of that meta-analysis is to show that none of these measures is decisively superior to the others. Grip strength wins on simplicity: one device, no space needed, no risk of falling.
Weakness thresholds, and how solid they are
The UK Biobank defines muscle weakness as strength below 26 kg in men and 16 kg in women, and that threshold is associated with higher risk for almost all the criteria studied. The European working group on sarcopenia, in its 2018 revision, made low muscle strength the central characteristic of sarcopenia and published its own cut offs.
Grip strength is also one of the five criteria of the frailty phenotype described in 2001, along with unintentional weight loss, exhaustion, slow walking and low physical activity. Three criteria out of five define frailty.
A threshold is not a diagnosis. It serves to trigger a sequence: a full strength assessment, a walking evaluation, and medical referral when the weakness is recent, asymmetric or accompanied by neurological signs.
Age norms, to interpret an isolated number
A number without a reference is useless. Twelve British studies, 49,964 participants and 60,803 measurements produced percentile curves from 4 to 90 years. They describe three periods: a rise to a peak in early adulthood, a plateau until the forties, then a decline.
The median peak is 51 kg in men between 29 and 39, 31 kg in women between 26 and 42. The prevalence of low strength, defined as at least 2.5 standard deviations below the peak, rises to 23% in men and 27% in women at 80.
These curves are British. They give an order of magnitude, not a national norm. The most solid use remains comparing a person with themselves, at six or twelve month intervals, with the same device.
How to measure without manufacturing noise
A review published in Age and Ageing in 2011 surveyed existing protocols and proposed a standardized procedure, because differences in method were enough to make studies incomparable. The elements that move the result are known: device type, sitting or standing position, elbow angle, handle setting, number of trials and verbal encouragement.
A procedure usable in practice: seated, elbow flexed at 90 degrees, handle adjusted to hand size, three trials per hand with a pause, and the maximum value is retained. Always the same device, always the same instruction, always recorded with the dominant hand.
The sensitivity analysis of the British curves indicates that their results remain valid despite differences in dynamometer and position. That holds for population averages, not for tracking one person, where a change of device can by itself create a gap.
The conclusions these data forbid
The PURE authors are explicit on this point: it remains to be demonstrated that improving strength reduces mortality. All the data presented here are observational. Low strength may be the sign of a disease already present rather than its cause.
That is the limit of the reasoning that consists of working the grip to improve prognosis. Grip strength is an indicator of the general state of muscle and nervous system, not a muscle to train for its own sake. Training a hand grip does not improve prognosis, and no study suggests it.
What can be said: it is an inexpensive, reproducible measure that ranks people with a strength comparable to that of usual biological markers, and that gives a concrete reason to start global strength work rather than an abstract discussion about aging.
Sources
- 1.Leong DP, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015.
- 2.Celis-Morales CA, et al. Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants. BMJ. 2018.
- 3.Cooper R, et al. Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ. 2010.
- 4.Dodds RM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014.
- 5.Roberts HC, et al. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age Ageing. 2011.
- 6.Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019.
- 7.Fried LP, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001.
Reading studies is one thing, turning them into a plan is another
The Longevity Practitioner certification teaches the method that turns this kind of data into an accompaniment decision: assess, prioritise, plan over 90 days, re-measure, and know when to hand over.
11 modules, €2,200. Enrol
Continue reading
Benjamin Sant
Co-founder of the School of Longevity
Cofounder of the School of Longevity with Tristan Maruyama. A former officer trained at Saint-Cyr from 2019 to 2022 and a coach since 2018, he has supported more than 4,000 people. He leads the School's editorial content with one constant principle: pass on only what can be situated, verified and applied seriously.
This article is published for information and education. It does not replace medical advice. For any personal health question, consult a healthcare professional.
